Insight Genetics | GenomeWeb

Insight Genetics

The company is developing molecular cancer diagnostics, including a test designed to monitor therapy resistance in non-small cell lung cancer patients.

The deal centers around ALK, a gene involved in signal transduction and a therapeutic target for non-small cell lung cancer.

WaferGen Biosystems said this week that it has appointed Keith Warner as chief operating officer and Michael Henighan as CFO.

Asuragen said this week that it has appointed Matthew McManus as CEO and president.

A team of researchers in Germany has developed a new assay to help determine which non-small cell lung cancers are likely to respond to certain targeted therapies.

NEW YORK (GenomeWeb News) – Insight Genetics is working with Vanderbilt-Ingram Cancer Center to identify genetic markers associated with treatment response for triple-negative breast cancer patients.

NEW YORK (GenomeWeb News) — Insight Genetics said yesterday that it has received a new $1.5 million grant from the National Cancer Institute.

NEW YORK (GenomeWeb News) – In June, Veracyte entered into a loan and security agreement with an unnamed financial institution for term loans of up to $10.0 million in aggregate, the company said in its recent Form 10-Q filed with the US Securities and Exchange Commission.

Nashville, Tenn.-based Insight Genetics said this week that it has launched Insight Molecular Labs, a CLIA-certified laboratory.

Insight Genetics this week announced an exclusive, worldwide licensing deal with St. Jude Children's Research Hospital for a genetic test to improve donor matching in bone marrow transplants.

Pages

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.